Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06607445Recruiting

Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.

Role: lead

NCT05513755Not ApplicableUnknown

Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)

Role: collaborator

NCT05420155Completed

Surgical Treatment of Liver Hydatid Cyst (SURGHIDA)

Role: collaborator

NCT05121181Completed

Reaching Consensus on the Definition of Difficult Cholecystectomy

Role: collaborator

NCT04271176Unknown

Jaundice as Initial Presentation of Liver Hydatidosis (ICTEHIDA)

Role: collaborator

NCT04151394Completed

Side-to-side Duodenojejunostomy After Distal Duodenal Resection (DUORESECT)

Role: collaborator

NCT02620358Not ApplicableCompleted

Two Opposite Strategies of Weaning From Mechanical Ventilation

Role: collaborator

All 7 trials loaded